• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Schering-Plough Corporation (NYSE: SGP)

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 32,000 people around the world. The company is based in Kenilworth, N.J *

 

	Start	1990-01-01 existent
	End	2009-11-03 merged
	Group	Merck (US) (Group)
	Today	Merck & Co. Inc. (NYSE: MRK)
	Successor	Merck & Co. Inc. (NYSE: MRK)
	Industry	pharmaceutical
	Region	Kenilworth, NJ
	Country	United States (USA)
	Street	2000 Galloping Hill Road
	City	07033-0530 Kenilworth, NJ
		Address record changed: 2008-12-07
Basic data	Employees	n. a.
		* Document for »About Section«: Schering-Plough Corporation. (11/9/06). "Press Release: Noxafil® (posaconazole) Oral Suspension Approved in European Union for Prevention of Invasive Fungal Infections. Treatment of Oropharyngeal Candidiasis (OPC) also Approved". Kenilworth, NJ.
		Record changed: 2011-11-25

More documents for Merck (US) (Group)

• [1] Bonislawski, Adam. (6/17/11). "News: BGI Aims to Expand Proteomics Services, Purchase 50-Plus New Mass Spectrometers"....
• [2] Metabolon, Inc.. (6/8/11). "Press Release: Metabolomics Study Reveals 3-Indaxyl Sulfate as a Sensitive and Early Biomarker of Nephrotoxicity Report Investigators from Merck and Metabolon". Research Triangle Park, NC....
• [3] Bonislawski, Adam. (2/18/11). "News: Pfizer Integrating Immunoaffinity Mass Spec into Drug Development Pipeline"....
• [4] Quotient Bioresearch Ltd.. (10/12/10). "Press Release: Quotient Bioresearch to Highlight Integrated Early Stage Drug Development Platforms at FIP Pharmaceutical Sciences World Congress 2010". Cambridgeshire, UK....
• [5] Caprotec Bioanalytics GmbH. (10/4/10). "Press Release: Caprotec Bioanalytics GmbH Appoints Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operationg Officer". Berlin & Burlington, MA....
• [6] Bruker Corporation. (5/29/09). "Press Release: Bruker Daltonics Announces Schering-Plough’s Selection of the New solariX FTMS for Structure Characterization and Impurity Testing". Billerica, MA....
• [7] Rosetta Biosoftware. (5/30/07). "Press Release: Waters Corporation and Rosetta Biosoftware Collaborate to Advance the Analysis of Complex Biological Mixture". Milford, MA & Seattle, WA....
• [8] Phytronix Technologies Inc.. (4/15/07). "Press Release: Publication of an Article in Analytical Chemistry"....
• [9] Rosetta Biosoftware. (5/26/06). "Press Release: Rosetta Biosoftware Announces the Availability of the Rosetta Elucidator Protein Expression Data Management and Analysis System Version 2.0". Seattle, WA....
• [10] Rosetta Biosoftware. (4/19/06). "Press Release: Rosetta Biosoftware and Sage-N Research, Inc. Collaborate on Informatics Environment for Proteomics and Biomarker Discovery". Seattle, WA....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.